title: Exertional rhabdomyolysis in an adolescent athlete during preseason conditioning: a perfect storm.
abstract: Cleary, MA, Sadowski, KA, Lee, SY-C, Miller, GL, and Nichols, AW. Exertional rhabdomyolysis in an adolescent athlete during preseason conditioning: a perfect storm. J Strength Cond Res 25(12): 3506-3513, 2011-The purpose of this brief review is to present a case of a healthy, male adolescent athlete (age = 16 years, body mass = 67.9 kg, height = 165.5 cm) who participated in a 3-day preseason wrestling camp which resulted in hospitalization for exertional rhabdomyolysis. As part of the preseason conditioning program directed by the coaches, the athlete completed 60 minutes of short, intense intervals of wall-sits, squats, sit-ups, push-ups, lunges, and plyometric jumps. The following day, the athlete continued his vigorous training consisting of running drills. That night he noticed voiding dark brown urine the color of cola. The day after the camp ended, the athlete reported to his Athletic Trainers with the chief complaint of severe bilateral leg pain in his quadriceps. Two days after the initial assessment, he was admitted to the hospital where he was diagnosed with exertional rhabdomyolysis based on creatine kinase (CK) levels that peaked at 146,000 IU·L, elevated far beyond normal (normal range = 58-280 IU·L). The athlete was hospitalized for 6 days where he received intravenous normal saline for rehydration, and his CK levels were assessed daily. Athletic Trainers, personal trainers, physical education teachers, and coaches should be aware that exertional rhabdomyolysis is the most common form of rhabdomyolysis and affects individuals who participate in novel and intense exercise to which they are unaccustomed. Stressful ambient conditions may lead to dehydration and exacerbation of the condition, particularly when the individual is not accustomed to the exercise intensity.
authors.affiliation: Department of Kinesiology and Rehabilitation Science, Human Performance Research Laboratory, University of Hawaii at Manoa, Honolulu, Hawaii, USA. mcleary@hawaii.edu
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Cleary
authors.forename: Kelsey A
authors.initials: KA
authors.lastname: Sadowski
authors.forename: Samuel Y-C
authors.initials: SY
authors.lastname: Lee
authors.forename: Gretchen L
authors.initials: GL
authors.lastname: Miller
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Nichols
mesh_terms: D000293:Adolescent; D000701:Analgesics, Opioid / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D015444:Exercise / Q000502:physiology*; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D009020:Morphine / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D014952:Wrestling / Q000502:physiology
chemical_list: D000701:Analgesics, Opioid; D009020:Morphine; D003402:Creatine Kinase